AbCellera Biologics Inc.

An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.

ABCL | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 150 W 4TH AVENUE, VANCOUVER
Website:: https://www.abcellera.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, AI-powered drug discovery platform that integrates advanced technologies in biology, computation, and engineering. This full-stack platform is designed to search, decode, and analyze natural immune systems at high speed and scale to find novel antibodies for therapeutic development. AbCellera partners with pharmaceutical and biotech companies to advance a pipeline of first-in-class and best-in-class antibody programs across various therapeutic areas, including cancer and endocrinology. The platform supports the development of complex modalities, such as bispecifics and antibody-drug conjugates, for conditions with high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AbCellera Biologics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbCellera Biologics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for AbCellera Biologics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Acticor Biotech Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.	France	ALACT
Acumen Pharmaceuticals, Inc. Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.	United States of America	ABOS
Adaptive Biotechnologies Corp Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.	United States of America	ADPT
Adecco Group AG Global talent solutions firm offering staffing, placement, career transition, and tech consulting.	Switzerland	ADI1
Adeia Inc. Invents and licenses foundational IP for the media and semiconductor industries.	United States of America	ADEA
ADforus Co., Ltd. Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.	South Korea	397810
Aditxt, Inc. Acquires and develops biotech for autoimmunity, cancer detection, and neuro diagnostics.	United States of America	ADTX
Adocia Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.	France	ADOC
ad pepper media International N.V. Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.	Germany	APM
Adtraction Group AB A partner marketing platform driving online sales for brands with a performance-based model.	Sweden	ADTR